VTv Therapeutics (NASDAQ:VTVT) is up 7% after hours following a boost to the majority stake held by Ron Perelman’s MacAndrews & Forbes.
Today the company exercised a right to cause MacAndrews & Forbes to buy 1.25M shares at $1.60 each – part of an agreement between the two reached Dec. 23.
MacAndrews & Forbes funded $2M to the company in return.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.